R&D Systems™ Recombinant Human SLITRK2 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human SLITRK2 Protein is derived from NS0. The Recombinant Human SLITRK2 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9H156
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 84631
• Molecular Weight (g/mol): Observed M.W.: 80-100kDa, reducing conditions, Theoretical M.W.: 68kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human SLITRK2 protein Thr19-Pro617,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: CXorf2, SLITL1, SLITRK2 SLIT and NTRK-like family, member 2
• Common Name: SLITRK2
• Gene Symbol: SLITRK2
• Biological Activity: Measured by its ability to inhibit neurite outgrowth of dissociated E13 chick embryonic dorsal root ganglia (DRG) neurons. Able to significantly inhibit neurite outgrowth when immobilized as a 3μL droplet containing 200 ng on a nitrocellulose-coated microplate.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Mouse myeloma cell line, NS0-derived Thr19-Pro617, with a C-terminal 6-His tag
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining